Your search for major depressive disorder returned 118 results

Reduction in caregiver depressive symptoms may have positive impact on child asthma outcomes, partially mediated by child depressive symptom severity

Researchers examined correlations between suicidal ideation and suicide attempt history in patients with treatment-resistant depression following ketamine infusion.

Researchers compared the white matter networks of patients with remitted major depressive disorder and remitted bipolar disorder to find disease-specific alterations.

Researchers examined associations between polygenic risk scores and neuropsychiatric conditions using data from phenome-wide association studies.

Screening for MDD recommended for teens aged 12 to 18 years; anxiety screening recommended for children aged 8 to 18 years

Researchers evaluated the efficacy of dextromorphan-bupropion among patients with major depressive disorder and comorbid anxiety.

Adults with major depressive disorder and a history of childhood trauma can still benefit from recommended depression treatments.

Researchers searched for protective effects in gut microbiota from the pathogenesis of major depressive disorder.

The FDA has cleared Nexstim’s NBT system for the treatment of major depressive disorder.

Screening recommended for those aged 12 to 18, however there is insufficient evidence to assess for children aged 11 and younger.